SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-23-000020
Filing Date
2023-05-03
Accepted
2023-05-03 08:02:43
Documents
14
Period of Report
2023-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20230503.htm   iXBRL 8-K 34270
2 EX-99.1 pcrx-3312023x991.htm EX-99.1 231360
6 PACIRA BIOSCIENCES LOGO pacirabiosciencesa01.jpg GRAPHIC 27796
  Complete submission text file 0001396814-23-000020.txt   465037

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20230503.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20230503_lab.xml EX-101.LAB 24132
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20230503_pre.xml EX-101.PRE 12516
8 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20230503_htm.xml XML 12015
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 23881747
SIC: 2834 Pharmaceutical Preparations